Science Explorer Back to mapMap
Discussion
Company · Gaithersburg · United States

Lentigen Technology (United States)

lentigen.com/homeROR OpenAlex
Research works
90
▲ 3% vs 2018-21
Citations
1.7k
19.2 per fractional work
Top-10% rate
19.7%
all institutions 10.0%
Open access
48%
world 40%
International
28%
world 18%
Lentigen Technology (United States)

Not ranked overall: Lentigen Technology (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Lentigen Technology (United States) work in?

In 2022-now, 58% of research at Lentigen Technology (United States) is in Health Sciences, 35% in Life Sciences. Its largest fields are Medicine (58%), Immunology and Microbiology (18%), Biochemistry, Genetics and Molecular Biology (16%). It does 2.1× the world's share of Health Sciences.

Health Sciences: 18 fractional works · 58.3% of its workMedicine: 18 fractional works · 58.3% of its workOncology: 14 fractional works · 42.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 3.8% of its workDermatology: 1 fractional works · 2.3% of its workSurgery: 0 fractional works · 1.6% of its workPathology and Forensic Medicine: 0 fractional works · 1.2% of its workImmunology and Allergy: 0 fractional works · 1.0% of its workPsychiatry and Mental health: 0 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.8% of its workHematology: 0 fractional works · 0.8% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.7% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.5% of its workInfectious Diseases: 0 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workGenetics: 0 fractional works · 0.2% of its workLife Sciences: 11 fractional works · 34.8% of its workImmunology and Microbiology: 6 fractional works · 18.5% of its workImmunology: 6 fractional works · 17.9% of its workVirology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 15.8% of its workMolecular Biology: 3 fractional works · 9.6% of its workGenetics: 2 fractional works · 5.0% of its workCancer Research: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.3% of its workBiological Psychiatry: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.1% of its workPhysical Sciences: 1 fractional works · 4.6% of its workPhysics and Astronomy: 1 fractional works · 1.9% of its workAstronomy and Astrophysics: 1 fractional works · 1.9% of its workEngineering: 1 fractional works · 1.7% of its workBiomedical Engineering: 0 fractional works · 1.2% of its workAerospace Engineering: 0 fractional works · 0.3% of its workElectrical and Electronic Engineering: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.6% of its workArtificial Intelligence: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.4% of its workEcology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workSocial Sciences: 1 fractional works · 2.3% of its workSocial Sciences: 1 fractional works · 1.9% of its workSociology and Political Science: 0 fractional works · 0.8% of its workAnthropology: 0 fractional works · 0.4% of its workTransportation: 0 fractional works · 0.4% of its workCommunication: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPsychology: 0 fractional works · 0.3% of its workClinical Psychology: 0 fractional works · 0.3% of its workALL ITS WORKLentigenTechnology…31fractional works, 2022-now
Life Sciences35%Physical Sciences5%Health Sciences58%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Medicine1858.3%
    1. Immunology and Microbiology618.5%
    2. Biochemistry, Genetics and Molecular Biology515.8%
    3. Neuroscience00.3%
    4. Agricultural and Biological Sciences00.1%
    1. Physics and Astronomy11.9%
    2. Engineering11.7%
    3. Computer Science00.6%
    4. Environmental Science00.4%
    1. Social Sciences11.9%
    2. Psychology00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.03× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.97× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 18.35× its world share, 6 worksImmunology and Micro…Neuroscience: 0.22× its world share, 0 worksNeuroscienceComputer Science: 0.07× its world share, 0 worksComputer ScienceEngineering: 0.12× its world share, 1 worksEngineeringEnvironmental Science: 0.08× its world share, 0 worksEnvironmental SciencePhysics and Astronomy: 0.85× its world share, 1 worksPhysics and AstronomyMedicine: 3.03× its world share, 18 worksMedicinePsychology: 0.12× its world share, 0 worksPsychologySocial Sciences: 0.15× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 18.4×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Immunology and Microbiology18.35×6 works
  2. Medicine3.03×18 works
  3. Biochemistry, Genetics and Molecular Biology2.97×5 works
  4. Physics and Astronomy0.85×1 works
  5. Neuroscience0.22×0 works
  6. Social Sciences0.15×1 works
  7. Engineering0.12×1 works
  8. Psychology0.12×0 works
  9. Environmental Science0.08×0 works
  10. Computer Science0.07×0 works
  11. Agricultural and Biological Sciences0.03×0 works

Who are the top researchers at Lentigen Technology (United States)?

Ranked on the quality score, Rimas J. Orentas, Dina Schneider and Boro Dropulić lead among researchers whose main affiliation is Lentigen Technology (United States).

  1. 1 Rimas J. Orentas United States · #112,961 worldwide 15k citations · 290 works
  2. 2 Dina Schneider United States · #129,409 worldwide 3.4k citations · 131 works
  3. 3 Boro Dropulić United States · #300,989 worldwide 6.8k citations · 173 works
  4. 4 Andrew Worden United States · #633,882 worldwide 1.5k citations · 26 works
  5. 5 Peirong Hu United States · #736,554 worldwide 1.1k citations · 46 works
  6. 6 Michael J. Kadan United States · #1,809,361 worldwide 1.2k citations · 24 works
  7. 7 Winfried Krüger United States · #2,452,976 worldwide 252 citations · 36 works
  8. 8 Heather D. Embree United States · #2,567,683 worldwide 754 citations · 21 works
  9. 9 Andre J Roy United States · #2,745,270 worldwide 827 citations · 47 works
All ranked researchers at Lentigen Technology (United States)

What are the most cited papers from Lentigen Technology (United States)?

The most cited paper from Lentigen Technology (United States) is "CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy" (Terry J. Fry et al., 2017), with 1,367 citations. Next come "Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial" (469) and "A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines" (265).

Most cited papers
#PaperReleasedCitations
1 CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy Terry J. Fry et al. · Nature Medicine Open access 20 Nov 2017 1,367
2 Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial Nirav Niranjan Shah, Bryon D. Johnson, Dina Schneider et al. · Nature Medicine Oct 2020 469
3 A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines Dina Schneider, Ying Xiong, Darong Wu et al. · Journal for ImmunoTherapy of Cancer Open access 8 May 2017 265
4 Towards a commercial process for the manufacture of genetically modified T cells for therapy A. Kaiser, Mario Assenmacher, Bernd Schröder et al. · Cancer Gene Therapy Open access 23 Jan 2015 205
5 CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR Haneen Shalabi et al. · Blood Open access 23 May 2022 180
All 60 most cited papers, with filters and sorting

Which keywords describe research at Lentigen Technology (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer Immunotherapy, Lymphoma, Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Glycosylation, Monoclonal Antibodies and Mammalian Cells.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Cancer Immunotherapy14▲ 294×3 topics
  2. Lymphoma13▲ 266×2 topics
  3. Immunotherapy13▲ 58×3 topics
  4. CAR T Cells13▲ 567×1 topic
  5. Chimeric Antigen Receptor13▲ 567×1 topic
  6. Glycosylation3▲ 90×2 topics
  7. Monoclonal Antibodies2▲ 78×2 topics
  8. Mammalian Cells2▲ 266×1 topic
  9. Recombinant Protein2▲ 266×1 topic
  10. NK Cell Recognition2▲ 93×1 topic
  11. Natural Killer Cells2▲ 93×1 topic
  12. AAV2▲ 125×1 topic
  13. Gene Therapy2▲ 27×2 topics
  14. Viral Vectors2▲ 125×1 topic
  15. Foxp31▲ 130×1 topic
  16. TGF-ß1▲ 28×1 topic
  17. Fc Receptors1▲ 70×1 topic
  18. Therapeutic Antibodies1▲ 55×1 topic
  19. Dendritic Cells1▲ 40×2 topics
  20. Immunity1▲ 8.3×2 topics
  21. Antigen Presentation1▲ 35×1 topic
  22. Tumor Antigen1▲ 52×1 topic

Which research topics does Lentigen Technology (United States) publish most on?

By volume in 2022-now: CAR-T cell therapy research, Viral Infectious Diseases and Gene Expression in Insects, Immune Cell Function and Interaction and Virus-based gene therapy research.

CAR-T cell therapy resea…13CAR-T cell therapy research: 13 fractional worksViral Infectious Diseases and Gene Expression in Insects: 2 fractional worksImmune Cell Function and Interaction: 2 fractional worksVirus-based gene therapy research: 2 fractional worksT-cell and B-cell Immunology: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksImmunotherapy and Immune Responses: 1 fractional worksBiosimilars and Bioanalytical Methods: 1 fractional worksCutaneous lymphoproliferative disorders research: 1 fractional worksXenotransplantation and immune response: 0 fractional works
OncologyMolecular BiologyImmunologyGenetics3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 13 works
  2. 2 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 2 works
  3. 3 Immune Cell Function and Interaction Immunology 2 works
  4. 4 Virus-based gene therapy research Genetics 2 works
  5. 5 T-cell and B-cell Immunology Immunology 1 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  7. 7 Immunotherapy and Immune Responses Immunology 1 works
  8. 8 Biosimilars and Bioanalytical Methods Immunology 1 works
  9. 9 Cutaneous lymphoproliferative disorders research Dermatology 1 works
  10. 10 Xenotransplantation and immune response Surgery 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.5%not open51.5%

World: 40% of research is openly available.

with international co-authors27.8%domestic only72.2%

World: 18% is written across borders.

How has Lentigen Technology (United States)'s research output changed?

Output in 2022-2025 was 3% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Lentigen Technology (United States) as a percentage of every work published that year, 0.00015% in 2024.

still counting0.00020%0.00040%Lentigen Technology (United States)0.00016% in 202519801990200020102020

Fractional works of Lentigen Technology (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Gaithersburg

All research institutions in Gaithersburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Lentigen Technology (United States). Posts are plain text and can be reported.